Abstract:Removing excessively produced cytokines is of paramount significance in blood purification therapy for hypercytokinemia-associated diseases. In this study, we devised a conduit that is modified with nanobodies (Nb) and incorporates static mixers (Nb-SMC) to eliminate surplus cytokines from the bloodstream. The low-pressure-drop (LPD) static mixer, with each unit featuring two 90°-crossed blades, was strategically arranged in a tessellated pattern on the inner wall of the conduit to induce turbulent mixing effects during the flow of blood. This arrangement enhances mass transfer and molecular diffusion, thereby assisting in the identification and elimination of cytokines. By utilizing computational fluid dynamics (CFD) studies, the Nb-SMC was rationally designed and prepared, ensuring an optimal interval between two mixer units (H/G = 2.5). The resulting Nb-SMC exhibited a remarkable selective clearance of IL-17A, reaching up to 85 %. Additionally, the process of Nb immobilization could be adjusted to achieve the simultaneous removal of multiple cytokines from the bloodstream. Notably, our Nb-SMC displayed good blood compatibility without potential adverse effects on the composition of human blood. As the sole documented static mixer-integrated conduit capable of selectively eliminating cytokines at their physiological concentrations, it holds promise in the clinical potential for hypercytokinemia in high-risk patients. STATEMENT OF SIGNIFICANCE: High-efficient cytokines removal in critical care still remains a challenge. The conduit technique we proposed here is a brand-new strategy for cytokines removal in blood purification therapy. On the one hand, nanobody endows the conduit with specific recognition of cytokine, on the other hand, the build-in static mixer enhances the diffusion of antigenic cytokine to the ligand. The combination of these two has jointly achieved the efficient and specific removal of cytokine. This innovative material is the only reported artificial biomaterial capable of selectively eliminating multiple cytokines under conditions close to clinical practice. It has the potential to improve outcomes for patients with hypercytokinemia and reduce the risk of adverse events associated with current treatment modalities.

A Novel Surface Modification and Immobilization Method of Anti-CD25 Antibody on Nonwoven Fabric Filter Removing Regulatory T Cells Selectively

Development of a disposable micro-capillary film grafted with peptide ligands for immunoadsorption.

Experimental and in Silico Studies on Three Hydrophobic Charge-Induction Adsorbents for Porcine Immunoglobulin Purification

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

Reducing Non-Specific Binding and Uptake of Nanoparticles and Improving Cell Targeting with an Antifouling PEO-b-PγMPS Copolymer Coating

Immobilization of Silver in Polypropylene Membrane for Anti-Biofouling Performance

Surface Chemical Modification of Poly(dimethylsiloxane) for Stabilizing Antibody Immobilization and T cell Cultures

Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

Antiviral functionalization of a polypropylene nonwoven textile structure as a self-decontaminating layer for respiratory masks

Antibody-functionalized Peptidic Membranes for Neutralization of Allogeneic Skin Antigen-Presenting Cells.

Surface Modification of Polypropylene Microfiltration Membranes by the Immobilization of Poly(n-Vinyl-2-pyrrolidone): a Facile Plasma Approach

Nanobody-loaded immunosorbent for highly-specific removal of interleukin-17A from blood

Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

Inhibition of non-specific protein adsorption on PMMA surface: The role of surface modification

Surface Modification of Polypropylene Microporous Membrane by Tethering Polypeptides

Poly(Acrolein-co- β-Cyclodextrin) Functionalized Magnetic Nanoparticles for Selective CD45-Positive Cells Capturing

Peptide-crosslinked IgG-imprinted polymers for antibody capture and separation

Nanobody-functionalized conduit with built-in static mixer for specific elimination of cytokines in hemoperfusion

Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody

Screening T-Cell Activity via a Photodetachable DNA-Copolymer Nanocage and Its Therapeutic Application

Expression and Purification of Recombinant Anti-human CD25 Chimeric Monoclonal Antibody